Lee Boram, Yang Changsop, Yim Mi Hong
KM Science Research Division, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 34054, Korea.
Digital Health Research Division, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 34054, Korea.
Healthcare (Basel). 2022 Jun 25;10(7):1192. doi: 10.3390/healthcare10071192.
Functional dyspepsia (FD) significantly reduces quality of life, and Korean medicine treatment, including herbal medicine, is frequently used in the clinical setting. We aimed to analyze the factors affecting Korean medicine health care (KMHC) use for FD. Data from the Korea Health Panel Survey 2017 were analyzed. Individuals aged > 19 years who were diagnosed with FD and used outpatient care were included. Multiple logistic regression analyses were performed to investigate the association of predisposing, enabling, and need factors with KMHC use for FD, based on Andersen’s behavioral model. The best subsets of factors affecting KMHC use for FD were selected using a stepwise procedure. Participants aged 65 years or older were less likely to use KMHC to treat FD than those aged 19 to 34 years (odds ratio (OR), 0.14; 95% confidence interval (CI), 0.02−0.93). Residents of Busan, Daegu, Ulsan, or Gyeongsang tended to use more KMHC to treat FD than those of Seoul, Gyeonggi, or Incheon (OR, 2.45; 95% CI, 1.02−5.88). Participants with private health insurance were more likely to use KMHC to treat FD than those without private health insurance (OR, 3.41; 95% CI, 1.02−11.42). The prediction model of KMHC use for FD selected sex, age, private health insurance, and stress as the best subset of factors (AUC, 0.709; 95% CI, 0.637−0.781). The results of this study will aid in the decision making of clinicians, researchers, and policymakers.
功能性消化不良(FD)会显著降低生活质量,在临床环境中,包括草药在内的韩医学治疗方法经常被使用。我们旨在分析影响韩医学医疗保健(KMHC)用于FD治疗的因素。对2017年韩国健康面板调查的数据进行了分析。纳入年龄大于19岁、被诊断为FD且使用门诊医疗服务的个体。基于安德森行为模型,进行了多项逻辑回归分析,以研究易患因素、促成因素和需求因素与KMHC用于FD治疗之间的关联。使用逐步程序选择影响KMHC用于FD治疗的最佳因素子集。65岁及以上的参与者使用KMHC治疗FD的可能性低于19至34岁的参与者(优势比(OR)为0.14;95%置信区间(CI)为0.02 - 0.93)。釜山、大邱、蔚山或庆尚道的居民比首尔、京畿道或仁川的居民更倾向于使用KMHC治疗FD(OR为2.45;95% CI为1.02 - 5.88)。拥有私人健康保险的参与者比没有私人健康保险的参与者更有可能使用KMHC治疗FD(OR为3.41;95% CI为1.02 - 11.42)。用于FD治疗的KMHC使用预测模型选择性别、年龄、私人健康保险和压力作为最佳因素子集(曲线下面积(AUC)为0.709;95% CI为0.637 - 0.781)。本研究结果将有助于临床医生、研究人员和政策制定者做出决策。
Evid Based Complement Alternat Med. 2022-1-29
BMC Complement Med Ther. 2022-6-20
Medicine (Baltimore). 2020-9-25
J Gastroenterol Hepatol. 2006-1
Healthcare (Basel). 2024-9-23
Evid Based Complement Alternat Med. 2022-1-29
J Gastroenterol Hepatol. 2019-7-4
Ann Occup Environ Med. 2018-10-19
Therap Adv Gastroenterol. 2018-7-16
J Neurogastroenterol Motil. 2018-10-1
United European Gastroenterol J. 2018-2
BMC Complement Altern Med. 2017-9-16
Eur J Gastroenterol Hepatol. 2017-5